PATENT CLAIM ANALYSIS

Application Number: 15748548
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "449000"]

Abstract:
The present invention provides a transdermal delivery system comprising (R)-dihydroetorphine, or a salt, hydrate or derivative thereof, wherein said system has a rapid onset of (R)-dihydroetorphine plasma concentration characterised by the mean in vivo plasma concentration of (R)-dihydroetorphine achieving at least 50% of its C max  in less than 20 hours, preferably in less than 18 hours and more preferably in less than 12 hours, after application of the system to the skin of a human subject, e.g. when based on the mean plasma concentration versus time curve.

Claim (Index 11):
A system as claimed in  claim 1 , wherein the mean in vivo plasma concentration of (R)-dihydroetorphine is 80 to 125% of 100 pg/ml in less than 12 hours after application of the system.

Metadata:
- Claim Count in Document: 96.0
- Percentile: 86.0
- Lexical Diversity: 1.65625
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14992122', '10736043', '11558663', '12181142', '10544259']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6840163230189873
- 35 USC 102 Novelty (BERT): 0.5065661098142858
- Combined Prediction Score: 0.6662713016985172
- Mean Citation Score: 174.41531
- Max Citation Score: 193.65048
- Similarity Product: 120.6679968831682

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test